On 15th November 2016, more than 70 patient advocates and physicians from across the European Union attended the Patient Advocacy and Safety conference at the European Parliament in Brussels, Belgium.
The aim of the conference was to explore the topic of biologics and biosimilars and how different policies and practices across Europe impact on patients. Patient advocates raised concerns around non-medical switching, tracking and traceability, and informed patient consent.
Click on the attached file to download the final report.
Date of issue: 2017-02-13